Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Price | 1d % | 1w % | 1m % | 3m % | 6m % | 1y % | 3y % | 5y % | 10y % | 52-week High | 52-week Low | % off 52-week High | % off 52-week Low | Beta | Volume | Vol 1d % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $311.02 | 2.37% | -0.44% | -5.80% | -9.89% | 27.30% | 69.03% | 37.24% | 19.16% | N/A | $385.22 | $172.67 | 19.26% | 80.12% | 1.00 | 187,000 | -11.79% |
| CORT | CORCEPT THERAPEUTICS INC | $38.20 | 9.77% | -53.78% | -52.70% | -55.31% | -46.45% | -23.55% | 89.39% | 46.42% | 719.74% | $117.33 | $32.99 | 67.44% | 15.79% | 0.94 | 6,703,000 | -66.99% |
| NVO | NOVO NORDISK A S | $52.39 | 2.97% | -0.02% | 10.46% | -10.81% | -24.96% | -40.14% | -23.50% | 46.69% | 82.86% | $93.80 | $43.08 | 44.15% | 21.61% | 0.64 | 12,078,000 | 11.79% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $400.17 | 0.63% | -0.10% | -13.93% | -13.19% | 21.35% | 71.29% | 71.31% | 212.39% | 330.15% | $495.55 | $205.87 | 19.25% | 94.38% | 0.92 | 730,000 | -5.07% |
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $42.01 | 1.83% | 0.01% | 4.83% | 12.10% | 53.08% | 110.66% | 190.89% | 146.07% | N/A | $44.42 | $17.82 | 5.44% | 135.72% | 0.83 | 709,000 | 165.54% |
| ZVRA | ZEVRA THERAPEUTICS INC | $8.34 | -6.92% | -5.98% | 2.08% | -10.42% | -11.37% | -4.79% | 84.11% | -20.19% | -97.17% | $13.16 | $6.19 | 36.63% | 34.73% | 0.90 | 940,000 | -30.06% |
| VCEL | VERICEL CORP | $35.61 | -1.11% | -5.44% | -5.42% | 12.98% | -14.11% | -35.38% | 41.70% | 15.13% | 1,307.51% | $63.00 | $29.24 | 43.48% | 21.79% | 1.50 | 488,000 | 27.08% |
| ARGX | ARGENX SE | $839.99 | -0.11% | -0.58% | -8.23% | 6.11% | 54.10% | 35.45% | 124.72% | 182.79% | N/A | $934.62 | $510.06 | 10.12% | 64.69% | 0.67 | 217,000 | 79.34% |
| KRYS | KRYSTAL BIOTECH INC | $246.91 | 0.15% | -2.09% | 14.81% | 35.90% | 74.68% | 57.77% | 211.64% | 315.53% | N/A | $265.92 | $122.80 | 7.15% | 101.07% | 1.37 | 197,000 | 0.51% |
| GMAB | GENMAB A | $31.82 | 3.31% | -4.79% | 0.35% | -0.93% | 55.68% | 51.52% | -26.05% | -21.93% | 136.65% | $33.96 | $17.24 | 6.30% | 84.62% | 0.72 | 1,947,000 | 0.31% |
| TECH | BIO-TECHNE CORP | $59.65 | 1.43% | 0.73% | -5.24% | -3.93% | 12.17% | -16.55% | -27.72% | -24.16% | 170.42% | $79.28 | $46.01 | 24.76% | 29.65% | 1.20 | 1,942,000 | 127.93% |
| LGND | LIGAND PHARMACEUTICALS INC | $190.11 | 0.55% | -2.92% | -2.56% | 5.55% | 67.26% | 75.35% | 187.91% | 88.10% | 85.53% | $212.49 | $93.58 | 10.53% | 103.15% | 1.16 | 206,000 | 134.09% |
| ADMA | ADMA BIOLOGICS INC | $17.88 | -1.97% | -7.26% | -7.12% | 23.06% | -1.43% | -0.50% | 362.02% | 747.39% | 126.90% | $25.67 | $13.50 | 30.35% | 32.44% | 1.23 | 1,973,000 | -0.10% |
| ABEO | ABEONA THERAPEUTICS INC | $5.31 | 0.76% | -2.57% | 16.70% | -0.19% | -9.54% | -10.15% | 85.66% | -87.43% | -93.79% | $7.54 | $3.93 | 29.58% | 35.01% | 0.87 | 1,126,000 | 22.26% |
| MNKD | MANNKIND CORP | $5.60 | -1.23% | -3.28% | 0.18% | 2.00% | 54.70% | -15.15% | 7.49% | 73.91% | -22.76% | $6.58 | $3.38 | 14.89% | 65.63% | 1.13 | 2,733,000 | 14.02% |
| VCYT | VERACYTE INC | $42.39 | 0.69% | -0.24% | -8.17% | 18.97% | 53.70% | 4.82% | 87.15% | -10.46% | 524.30% | $50.71 | $22.61 | 16.41% | 87.48% | 1.97 | 493,000 | -12.12% |
| RPRX | ROYALTY PHARMA PLC | $38.86 | 0.57% | -0.92% | -1.69% | 6.49% | 7.38% | 50.68% | -1.37% | -17.02% | N/A | $41.24 | $25.40 | 5.77% | 52.99% | 0.49 | 3,203,000 | 37.35% |
| CRMD | CORMEDIX INC | $12.16 | 4.56% | -2.95% | 24.34% | 10.05% | 4.92% | 47.93% | 190.91% | 64.77% | 28.00% | $17.43 | $5.60 | 30.24% | 117.14% | 1.08 | 2,157,000 | -40.12% |
| NAGE | NIAGEN BIOSCIENCE INC | $6.25 | -1.73% | -5.87% | -2.34% | -15.31% | -50.32% | 14.05% | 269.82% | 31.58% | 70.77% | $14.69 | $5.16 | 57.45% | 21.12% | 1.36 | 656,000 | -23.72% |
| EXEL | EXELIXIS INC | $43.58 | -0.57% | -5.75% | 0.32% | 5.39% | -1.63% | 28.40% | 167.36% | 112.27% | 693.81% | $49.62 | $31.90 | 12.17% | 36.61% | 0.62 | 2,489,000 | 41.66% |
| VRTX | VERTEX PHARMACEUTICALS INC | $452.13 | -0.27% | -2.33% | 4.38% | 10.59% | -1.07% | 11.43% | 58.08% | 97.07% | 267.91% | $519.68 | $362.50 | 13.00% | 24.73% | 0.57 | 825,000 | 19.05% |
| HALO | HALOZYME THERAPEUTICS INC | $70.31 | 4.47% | 2.09% | 5.67% | -1.92% | 30.59% | 46.45% | 27.53% | 65.79% | 322.54% | $79.50 | $47.50 | 11.56% | 48.02% | 0.84 | 2,441,000 | 149.85% |
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.74 | -3.33% | -3.87% | 4.19% | -25.64% | 16.00% | -11.68% | 27.01% | -51.40% | -82.77% | $3.10 | $1.32 | 43.87% | 31.82% | 0.73 | 591,000 | -5.44% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $59.45 | 0.03% | -0.83% | 10.32% | 6.98% | 3.99% | -10.59% | -40.91% | -31.11% | -43.34% | $73.51 | $50.76 | 19.13% | 17.12% | 0.75 | 1,143,000 | -18.30% |
| APLS | APELLIS PHARMACEUTICALS INC | $25.86 | 2.95% | 3.56% | 25.17% | 11.90% | 45.12% | -22.01% | -48.57% | -52.63% | N/A | $35.57 | $16.10 | 27.30% | 60.62% | 0.99 | 3,275,000 | 242.57% |
| AUPH | AURINIA PHARMACEUTICALS INC | $15.35 | -3.76% | -5.54% | -3.52% | 36.32% | 104.94% | 75.03% | 158.42% | 13.37% | 539.58% | $16.54 | $6.55 | 7.19% | 134.35% | 1.13 | 1,675,000 | 150.75% |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $37.38 | -0.11% | -1.97% | 3.80% | 39.69% | 16.41% | 7.32% | -29.42% | 5.50% | N/A | $40.93 | $25.52 | 8.67% | 46.47% | 0.81 | 522,000 | 30.50% |
| CPRX | CATALYST PHARMACEUTICALS INC | $23.15 | -0.81% | -4.93% | 2.34% | 11.08% | 7.93% | 7.57% | 28.18% | 555.81% | 897.84% | $26.58 | $19.05 | 12.90% | 21.52% | 1.04 | 993,000 | 19.78% |
| MDXG | MIMEDX GROUP INC | $6.48 | -4.28% | -6.09% | -3.57% | -3.43% | 4.01% | -30.17% | 118.18% | -29.26% | -27.68% | $9.36 | $5.79 | 30.78% | 11.92% | 1.27 | 809,000 | 49.81% |
| INVA | INNOVIVA INC | $19.87 | -0.60% | 0.35% | -5.29% | 12.55% | 2.42% | 14.20% | 49.74% | 59.21% | 92.54% | $22.76 | $16.52 | 12.70% | 20.28% | 0.41 | 453,000 | -19.54% |
| REGN | REGENERON PHARMACEUTICALS INC | $776.31 | 0.58% | -1.10% | 4.62% | 29.39% | 41.73% | 8.55% | 7.75% | 60.77% | 50.29% | $792.77 | $476.49 | 2.08% | 62.92% | 0.61 | 465,000 | 30.99% |
| UTHR | UNITED THERAPEUTICS CORP | $496.72 | 1.94% | -2.06% | 4.76% | 12.02% | 68.25% | 37.89% | 81.74% | 222.67% | 219.35% | $519.99 | $266.98 | 4.48% | 86.05% | 0.45 | 523,000 | 50.29% |
| ACAD | ACADIA PHARMACEUTICALS INC | $26.29 | -1.57% | -4.82% | 3.38% | 22.97% | 23.78% | 40.89% | 61.09% | -50.22% | -24.06% | $28.35 | $13.40 | 7.27% | 96.19% | 0.94 | 1,666,000 | 116.93% |
| INCY | INCYTE CORP | $101.42 | 2.68% | 1.31% | -0.02% | 17.55% | 48.78% | 45.87% | 27.49% | 17.32% | -1.84% | $109.28 | $53.56 | 7.19% | 89.36% | 0.57 | 2,152,000 | 56.28% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.